People | Page 428 of 525 | SpiritIndia.com

Health :: Predicting PET Imaging’s Future: Diagnosing and Treating Diseases ASAP

Breakthroughs in Sensitivity and Resolution Benefit Patients, Fundamentally Change How Doctors Will Diagnose and Treat Cancer and Heart, Brain Diseases, Notes Article in November Journal of Nuclear Medicine – Imagine a new world of detecting and diagnosing diseases sooner?even before any symptoms are present. Consider the possibility of receiving individualized, targeted molecular, cellular or genetic medical treatment as soon as possible and of undergoing scanning that can quickly tell your doctor whether your treatment is working. Continued advances in positron emission tomography (PET) imaging are key to this future, according to Simon R. Cherry, professor of biomedical engineering at the University of California, Davis.

Health :: Carers need emotional support as well as practical help

Seeing the funny side of things and realising that other people are worse off than them are the two top coping strategies used by people caring for someone over 75, according to research in November issue of Journal of Clinical Nursing.

Depression :: Regular follow-up important during antidepressant treatment

Because individuals can react differently to antidepressant medications, regular follow-up is important during the first few weeks of treatment, according to an editorial by Group Health psychiatrist and researcher Greg Simon, MD, MPH.

Multiple Sclerosis :: More money for disease modifying drug therapies in Wales

On 30 October 2006, Dr Brian Gibbons, Health Minister for Wales, announced an additional ?700,000 funding for the beta interferons and glatiramer acetate. This should help to ensure that everyone with MS who lives in Wales and meets the prescribing criteria will be able to start treatment as soon as possible.

Multiple Sclerosis :: Vitamin B12 and Multiple Sclerosis, MS

A Durham GP is calling for people to be routinely screened for B12 deficiency as he believes that this is the cause of symptoms that are often ascribed to other conditions.

Health :: Staph Vaccine Shows Promise in Staphylococcus infections

By combining four proteins of Staphylococcus aureus that individually generated the strongest immune response in mice, scientists have created a vaccine that significantly protects the animals from diverse strains of the bacterium that cause disease in humans. A report describing the University of Chicago study, funded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, appears online this week in the Proceedings of the National Academy of Sciences.

Kidney Stone :: Drug prescribed for migraines and seizures increases risk of kidney stones

Topiramate (Topamax), a drug commonly prescribed to treat seizures and migraine headaches, can increase the propensity of calcium phosphate kidney stones, researchers at UT Southwestern Medical Center have found.

Depression :: Carefully monitored treatment can help two-thirds of those who suffer from depression

More than two-thirds of people who suffer from major depression can become symptom-free if they are willing to work with their doctors and try various treatments to determine which work best for them, which may involve taking different antidepressants or adding cognitive therapy to the mix.

Stroke :: Two-Week Regimen Helps Stroke Survivors Regain Arm Control

In the largest, most comprehensive study of its kind to date, researchers supported by the National Institutes of Health (NIH) showed clinical improvements out to one year when stroke survivors who had lost function in one arm were given a unique, two-week rehabilitation regimen.

Macular Degeneration :: Laser Treatment Does Not Prevent Vision Loss for People with Early Age-Related Macular Degeneration

An extensive NIH-supported study has found that low-intensity laser treatment, thought to be possibly beneficial in slowing or preventing the loss of vision from age-related macular degeneration (AMD), is ineffective in preventing complications of AMD or loss of vision. This is the major conclusion of the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT), a research study of more than 1,000 people that will be published in the November 2006 issue of the journal Ophthalmology. The study was supported by grants from the National Eye Institute (NEI) of the National Institutes of Health (NIH).